Safety and efficacy of nintedanib (BIBF 1120) plus pemetrexed in Japanese patients with advanced or recurrent non-small cell lung cancer (NSCLC): A phase I study

被引：0
|
作者：
Daga, Haruko
Takeda, Koji
Okada, Hideaki
Miyazaki, Masaki
Ueda, Shinya
Kaneda, Hiroyasu
Okamoto, Isamu
Yoh, Kiyotaka
Goto, Koichi
Konishi, Koichi
Sarashina, Akiko
Yagi, Nobutaka
Mera, Kiyomi
Kaiser, Rolf
Nakagawa, Kazuhiko
机构：
[1] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan
[2] Kinki Univ, Dept Med Oncol, Osaka, Japan
[3] Kinki Univ, Osakasayama, Japan
[4] Natl Canc Ctr Hosp East, Div Thorac Oncol, Chiba, Japan
[5] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan
[6] Nippon Boehringer Ingelheim Co Ltd, Med Dev Div, Tokyo, Japan
[7] Nippon Boehringer Ingelheim Co Ltd, Med Dev Div, Kobe, Hyogo, Japan
[8] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[9] Kinki Univ, Fac Med, Higashiosaka, Osaka 577, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8056
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PEMETREXED MONOTHERAPY FOR JAPANESE PATIENTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Sato, Akira
    Misumi, Yuki
    Kashizaki, Fumihiro
    Ishii, Mari
    Shimokawa, Tsuneo
    Hida, Naoya
    Okamoto, Hiroaki
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1213 - S1214
  • [32] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [33] A population pharmacokinetic analysis for BIBF 1120, an angiokinase inhibitor, in patients with advanced non-small-cell lung cancer (NSCLC)
    Freiwald, M.
    Liesenfeld, K.
    Bruno, R.
    Hodge, L.
    Stopfer, P.
    Eschbach, C.
    Reck, M.
    von Pawel, J.
    Kaiser, R.
    Staab, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Tamiya, Akihiro
    Morimoto, Masahiro
    Fukuda, Shoichi
    Naoki, Yoko
    Ibe, Tatsuya
    Okishio, Kyoichi
    Goto, Hideto
    Yoshii, Akihiro
    Kita, Toshiyuki
    Nogami, Naoyuki
    Fujita, Yuka
    Atagi, Shinji
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (04) : 667 - 673
  • [35] A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Akihiro Tamiya
    Masahiro Morimoto
    Shoichi Fukuda
    Yoko Naoki
    Tatsuya Ibe
    Kyoichi Okishio
    Hideto Goto
    Akihiro Yoshii
    Toshiyuki Kita
    Naoyuki Nogami
    Yuka Fujita
    Shinji Atagi
    Investigational New Drugs, 2018, 36 : 667 - 673
  • [36] Phase I Study of Nivolumab and Ipilimumab Combined with Nintedanib in Advanced Non-Small Cell Lung Cancer
    Puri, S.
    Guadalupe, N. Rodriguez
    Niyongere, S.
    Boyle, T.
    Thapa, R.
    Chen, D.
    Noyes, D.
    Chatwal, M.
    Antonia, S.
    Gray, J. E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S640 - S641
  • [37] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Manegold, C.
    Digumarti, R.
    Zukin, M.
    de Marinis, F.
    Mellerngaard, A.
    Gandara, D.
    Simms, L.
    Kaiser, C.
    Blatter, J.
    Gatzemeier, U.
    EJC SUPPLEMENTS, 2007, 5 (06): : 9 - 9
  • [38] Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Purvish, Parikh
    von Pawel, Joachim
    Biesma, Bonna
    Vansteenkiste, Johan
    Manegold, Christian
    Simms, Lorinda
    Posther, Sugarman Katherine
    Obasaju, Coleman
    Blatter, Johannes
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S306
  • [39] Phase I/II trial of bortezimib and pemetrexed in patients with advanced non-small cell lung cancer
    Natale, R. B.
    McKinley, M.
    Hilger, J.
    Myers, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] EFFICACY AND SAFETY OF CISPLATIN/PEMETREXED AS FIRST-LINE TREATMENT FOR JAPANESE PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Yamaguchi, Teppei
    Nakanishi, Toru
    Hayashi, Masamichi
    Isogai, Sumito
    Hoshino, Tami
    Mieno, Yuki
    Uozu, Sakurako
    Morishita, Mariko
    Okamura, Takuya
    Takeyama, Tomoko
    Minezawa, Tomoyuki
    Morikawa, Sayako
    Niwa, Yoshikazu
    Okazawa, Mitsushi
    Imaizumi, Kazuyoshi
    RESPIROLOGY, 2013, 18 : 83 - 83
12345